Retatrutide (LY-3437943) is an experimental drug for obesity . It is a triple hormone receptor agonist of GLP-1, GIP, and GCGR receptors. It has been shown to achieve a more than 24% mean weight reduction in non-diabetic obese or overweight adults during a phase 2 trial.

Tirzepatide, brand name Mounjaro, is used for the treatment of type 2 diabetes.

is FDA approved for weight loss.

AC-EEMQRRAD

D-ALA2-LEU5-ENKEPHALIN

COLL-O2，Tripeptide

pyrrolidine-2-carbonyl)-4-hydroxypyrrolidine-2-carboxylic acid,Tripeptide-29;CollagenTripeptide;

Cosmetic Raw Materials High-Purity Cosmetic Peptide Syn-Ake CAS 823202-99-9